Table 1. Relationship between circAHNAK1 and clinical-pathological features of TNBC.
| Variables | Cases(n=136) | circAHNAK1 | P value | |
| Low No.(N=68) | High No.(N=68) | |||
| Age(years) | ||||
| <40 | 35 | 15(42.9%) | 20(57.1%) | 0.393 |
| 40-60 | 87 | 44(50.6%) | 43(49.4%) | |
| >60 | 14 | 9(64.3%) | 5(35.7%) | |
| Menopause | ||||
| No | 82 | 41(50.0%) | 41(50.0%) | 1.000 |
| Yes | 54 | 27(50.0%) | 27(50.0%) | |
| T stage | ||||
| T1-T2 | 122 | 57(46.7%) | 65(53.3%) | 0.045* |
| T3-T4 | 14 | 11(78.6%) | 3(21.4%) | |
| N stage | ||||
| N0 | 75 | 27(36.0%) | 48(64.0%) | 0.001* |
| N1-3 | 61 | 41(67.2%) | 20(32.8%) | |
| TNM stage | ||||
| I-II | 107 | 43(40.2%) | 64(59.8%) | <0.001* |
| III-IV | 29 | 25(86.2%) | 4(13.8%) | |
*P < 0.05, statistically significant